Saturday 17 October 2026
Export ADUS’s income statement to Excel — free account
Addus HomeCare Corporation
ADUS Healthcare Medical Care Facilities
Addus HomeCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 23.2% from fiscal 2024. In the quarter to June 2026, revenue grew 8.01%, EPS grew 24.2%, free cash flow grew 81.7% and total debt fell 63.6%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
116.05
0.44
−0.38%
Follow ADUS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
8.58% | 9.33% | 9.45% | 9.71% | |
Piotroski F-Score |
5 | 7 | 7 | 6 | |
| 6.65% | 6.73% | 7.02% | 7.35% | ||
ROIC |
7.01% | 7.70% | 8.05% | 8.34% | |
Return on Tangible Assets |
66.76% | 66.14% | 67.37% | 75.30% | |
Average Days of Receivables |
36.33 | 38.92 | 36.49 | 35.88 | |
Free Cash Flow per Share |
5.34 | 5.75 | 7.55 | 8.46 | |
Free Cash Flow |
96.42 | 103.80 | 137.40 | 154.80 | |
Capital Expenditures |
(6.74) | (7.70) | (7.52) | (7.60) | |
| Other line items | |||||
Cash ROIC |
7.40% | 8.06% | 10.48% | 11.82% | |
Accounts Receivable Turnover |
11.68 | 10.36 | 10.37 | 10.35 | |
Accounts Payable Turnover |
40.85 | 43.66 | 46.58 | 59.22 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
6.71 | 6.40 | 5.24 | 6.59 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.25) | (0.25) | (0.25) | (0.25) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
22.35% | 21.57% | 21.50% | 21.19% | |
Share Based Compensation of Revenue |
1.09% | 1.15% | 1.26% | 1.23% | |
Interest Coverage |
9.36 | 10.18 | 12.11 | 14.91 | |
Operating CF/Net income |
1.20 | 1.16 | 1.45 | 1.54 | |
Depreciation/Fixed assets |
0.69 | 0.71 | 0.72 | 0.76 | |
Capex/Depreciation |
(0.40) | (0.44) | (0.42) | (0.42) | |
Revenue per Share |
74.51 | 78.80 | 79.61 | 80.71 | |
Operating CF per Share |
5.71 | 6.18 | 7.97 | 8.88 | |
Capex per Share |
(0.37) | (0.43) | (0.41) | (0.42) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates